Flagship Ventures Fund 2004 L P insider trades: BIND Therapeutics (BIND) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Flagship Ventures Fund 2004 L P reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 25, 2013 | BIND | ↑ Buy | 20,000 | $15.00 | $300K | Indirect | Sep 27, 2013 (2d) |
| Mar 25, 2013 | TTPH | ↑ Buy | 491,824 | $7.00 | $3.4M | Direct | Mar 27, 2013 (2d) |
| May 30, 2007 | HLCS | ↑ Buy | 222,222 | $9.00 | $2.0M | Indirect | May 31, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Flagship Ventures Fund 2004 L P's insider trades
Flagship Ventures Fund 2004 L P is a 10% owner of BIND Therapeutics (BIND). Since May 30, 2007, it has reported 3 open-market purchases worth $5.7M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (6 filings), grants and awards (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIND insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.